chrX-71290753-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_007363.5(NONO):c.116C>T(p.Pro39Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000672 in 1,189,845 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.0000065 ( 0 hom. 3 hem. )
Consequence
NONO
NM_007363.5 missense
NM_007363.5 missense
Scores
5
12
Clinical Significance
Conservation
PhyloP100: 2.33
Genes affected
NONO (HGNC:7871): (non-POU domain containing octamer binding) This gene encodes an RNA-binding protein which plays various roles in the nucleus, including transcriptional regulation and RNA splicing. A rearrangement between this gene and the transcription factor E3 gene has been observed in papillary renal cell carcinoma. Alternatively spliced transcript variants have been described. Pseudogenes exist on Chromosomes 2 and 16. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), NONO. . Gene score misZ 3.5885 (greater than the threshold 3.09). GenCC has associacion of gene with X-linked syndromic intellectual disability, autism, susceptibility to, 15, syndromic X-linked intellectual disability 34.
BP4
Computational evidence support a benign effect (MetaRNN=0.17574915).
BS2
High Hemizygotes in GnomAdExome4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NONO | NM_007363.5 | c.116C>T | p.Pro39Leu | missense_variant | 3/12 | ENST00000276079.13 | NP_031389.3 | |
NONO | NM_001145408.2 | c.116C>T | p.Pro39Leu | missense_variant | 4/13 | NP_001138880.1 | ||
NONO | NM_001145409.2 | c.116C>T | p.Pro39Leu | missense_variant | 2/11 | NP_001138881.1 | ||
NONO | NM_001145410.2 | c.-113-1026C>T | intron_variant | NP_001138882.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NONO | ENST00000276079.13 | c.116C>T | p.Pro39Leu | missense_variant | 3/12 | 1 | NM_007363.5 | ENSP00000276079 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000890 AC: 1AN: 112297Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34457
GnomAD3 genomes
AF:
AC:
1
AN:
112297
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34457
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000209 AC: 3AN: 143829Hom.: 0 AF XY: 0.0000251 AC XY: 1AN XY: 39815
GnomAD3 exomes
AF:
AC:
3
AN:
143829
Hom.:
AF XY:
AC XY:
1
AN XY:
39815
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000650 AC: 7AN: 1077496Hom.: 0 Cov.: 30 AF XY: 0.00000861 AC XY: 3AN XY: 348400
GnomAD4 exome
AF:
AC:
7
AN:
1077496
Hom.:
Cov.:
30
AF XY:
AC XY:
3
AN XY:
348400
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000890 AC: 1AN: 112349Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34519
GnomAD4 genome
AF:
AC:
1
AN:
112349
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34519
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 05, 2022 | Variant summary: NONO c.116C>T (p.Pro39Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.1e-05 in 143829 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.116C>T in individuals affected with X-Linked Mental Retardation, Syndromic 34 and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
See cases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University Hospital Muenster | Mar 01, 2023 | ACMG categories: PP1,PP2,BP1 - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 14, 2023 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 39 of the NONO protein (p.Pro39Leu). This variant is present in population databases (rs755285551, gnomAD 0.01%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with NONO-related conditions. ClinVar contains an entry for this variant (Variation ID: 1704517). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt NONO protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L;.;.;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N;D;N
REVEL
Benign
Sift
Uncertain
D;D;D;D;D;D;D
Sift4G
Benign
T;T;T;T;T;D;T
Polyphen
P;P;P;.;.;.;.
Vest4
MutPred
Loss of glycosylation at P39 (P = 4e-04);Loss of glycosylation at P39 (P = 4e-04);Loss of glycosylation at P39 (P = 4e-04);Loss of glycosylation at P39 (P = 4e-04);Loss of glycosylation at P39 (P = 4e-04);Loss of glycosylation at P39 (P = 4e-04);Loss of glycosylation at P39 (P = 4e-04);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at